Skip to main content

Advertisement

Log in

Celiac disease in non-clinical populations of Japan

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Celiac disease is a chronic autoimmune enteropathy caused by gluten ingestion. While its prevalence in Western countries is reported to be as high as 1%, the prevalence has not been evaluated in a large-scale study of a Japanese population. The aim of our study was to clarify the possible presence of celiac disease in a Japanese non-clinical population as well as in patients showing symptoms suggestive of the disease.

Methods

Serum samples were collected from 2008 non-clinical adults and 47 patients with chronic unexplained abdominal symptoms between April 2014 and June 2016. The anti-tissue transglutaminase (TTG) immunoglobulin A antibody titer was determined as a screening test for celiac disease in all subjects, and individuals with a value of >2 U/mL subsequently underwent testing for the presence of serum endomysial IgA antibody (EMA) as confirmation. Those testing positive for EMA or with a high concentration (>10 U/mL) of TTG were further investigated by histopathological examinations of duodenal mucosal biopsy specimens and HLA typing tests.

Results

Of the 2008 non-clinical adults from whom serum samples were collected, 161 tested positive for TTG, and all tested negative for EMA. Four subjects who had a high TTG titer were invited to undergo confirmatory testing, and the histopathological results confirmed the presence of celiac disease in only a single case (0.05%). Of the 47 symptomatic patients, one (2.1%) was found to have a high TTG titer and was diagnosed with celiac disease based on duodenal histopathological findings.

Conclusion

The presence of celiac disease in a non-clinical Japanese population was low at 0.05% and was rarely found in patients with unexplained chronic abdominal symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012;367:2419–26.

    Article  CAS  PubMed  Google Scholar 

  4. Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009;169:651–8.

    Article  PubMed  Google Scholar 

  5. Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol. 2012;34:473–8.

    Article  PubMed  Google Scholar 

  6. van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46.

    Article  PubMed  Google Scholar 

  7. Oxentenko AS, Murray JA. Celiac disease: ten things that every gastroenterologist should know. Clin Gastroenterol Hepatol. 2015;13:1396–404.

    Article  PubMed  Google Scholar 

  8. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012;18:6036–59.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Vives-Pi M, Takasawa S, Pujol-Autonell I, et al. Biomarkers for diagnosis and monitoring of celiac disease. J Clin Gastroenterol. 2013;47:308–13.

    Article  CAS  PubMed  Google Scholar 

  10. Fernandez E, Riestra S, Rodrigo L, et al. Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population. World J Gastroenterol. 2005;11:3762–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Srinivas M, Basumani P, Podmore G, et al. Utility of testing patients, on presentation, for serologic features of celiac disease. Clin Gastroenterol Hepatol. 2014;12:946–52.

    Article  PubMed  Google Scholar 

  12. Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology. 2005;128:S33–7.

    Article  PubMed  Google Scholar 

  13. Kang JY, Kang AH, Green A, et al. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45.

    Article  CAS  PubMed  Google Scholar 

  14. Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology. 2005;128:S47–51.

    Article  PubMed  Google Scholar 

  15. West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109:757–68.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hall EH, Crowe SE. Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment. Dig Dis. 2011;29:249–54.

    Article  PubMed  Google Scholar 

  17. Ihara M, Makino F, Sawada H, et al. Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. Intern Med. 2006;45:135–40.

    Article  PubMed  Google Scholar 

  18. Ohata C, Ishii N, Hamada T, et al. Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years. Clin Dev Immunol. 2012;2012:562168.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Watanabe C, Komoto S, Hokari R, et al. Prevalence of serum celiac antibody in patients with IBD in Japan. J Gastroenterol. 2014;49:825–34.

    Article  CAS  PubMed  Google Scholar 

  20. Katanoda K, Matsumura Y. National nutrition survey in Japan–its methodological transition and current findings. J Nutr Sci Vitaminol (Tokyo). 2002;48:423–32.

    Article  CAS  Google Scholar 

  21. Ministry of Health, Labour and Welfare. National health and nutrition survey. www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/kenkou/kenkounippon21/en/eiyouchousa/koumoku_syokuhin_chousa.html. Accessed 25 Mar 2017.

  22. Liu E, Lee HS, Aronsson CA, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371:42–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bonatto MW, Kotze L, Orlandoski M, et al. Endoscopic evaluation of celiac disease severity and its correlation with histopathological aspects of the duodenal mucosa. Endosc Int Open. 2016;4:E767–77.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–54.

    Article  CAS  PubMed  Google Scholar 

  25. Villanacci V, Ceppa P, Tavani E, et al. Coeliac disease: the histology report. Dig Liver Dis. 2011;43[Suppl 4]:S385–95.

    Article  PubMed  Google Scholar 

  26. Muniz JG, Sdepanian VL, Fagundes UN. Prevalence of genetic susceptibility for celiac disease in blood donors in Sao Paulo. Brazil Arq Gastroenterol. 2016;53:267–72.

    Article  PubMed  Google Scholar 

  27. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.

    Article  PubMed  Google Scholar 

  28. Saito S, Ota S, Yamada E, et al. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 2000;56:522–9.

    Article  CAS  PubMed  Google Scholar 

  29. Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017;112:65–76.

    Article  PubMed  Google Scholar 

  30. Petrarca L, Nenna R, Mastrogiorgio G, et al. Dyspepsia and celiac disease: prevalence, diagnostic tools and therapy. World J Methodol. 2014;4:189–96.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Sanchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M, et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case–control study. Neurogastroenterol Motil. 2016;28:994–1000.

    Article  CAS  PubMed  Google Scholar 

  32. Di Tola M, Marino M, Goetze S, et al. Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study. J Gastroenterol. 2016;51:1031–9.

    Article  PubMed  Google Scholar 

  33. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ. 2007;335:1244–7.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Hill P, Austin A, Forsyth J, et al. British Society of Gastroenterology guidelines on the diagnosis and management of coeliac disease. Gut. 2015;64:691–2.

    Article  PubMed  Google Scholar 

  35. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147:294–302.

    Article  PubMed  Google Scholar 

  36. Kim CY, Quarsten H, Bergseng E, et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA. 2004;101:4175–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lundin KE, Gjertsen HA, Scott H, et al. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994;41:24–7.

    Article  CAS  PubMed  Google Scholar 

  38. Paulsen G, Lundin KE, Gjertsen HA, et al. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. Hum Immunol. 1995;42:145–53.

    Article  CAS  PubMed  Google Scholar 

  39. Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol. 2008;103:997–1003.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Takashi Toda, and Atsuko Konishi (Shimane Environment and Health Public Corporation) for blood sample preparation. We also thank Keiko Masuzaki (Shimane University School of Medicine) for excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norihisa Ishimura.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukunaga, M., Ishimura, N., Fukuyama, C. et al. Celiac disease in non-clinical populations of Japan. J Gastroenterol 53, 208–214 (2018). https://doi.org/10.1007/s00535-017-1339-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-017-1339-9

Keywords

Navigation